Tag Archives: alzheimer’s disease
A new trehalose-conjugated peptide protects neurons from Aβ’s oligomers insult
Management of apathy in the long-term care setting
Trapping copper with peptides to diminish metal-related toxicity in Alzheimer’s disease
Early-onset Alzheimer disease: what are we missing?
Memory is the first brain function that starts to fade away when Alzheimer disease (AD) pathology affects the brain of a patient. Decline of additional cognitive functions, shortly follows. This progressive and irreversible disease, intrudes the life
Mutations in the SORL1 gene affect risk of early-onset Alzheimer’s disease
Regional Alzheimer’s disease research
According to World Alzheimer Report 2015, over 46 million people live with dementia worldwide. The incidence of dementia is estimated over 9.9 million every year, and nearly half of new dementia cases (4.9 million) occurred in Asia.
One of the mechanisms of amyloid fibrils formation based on the sizes of folding nuclei of Aβ40 and Aβ42
Differential courses of delay discounting in mild cognitive impairment and Alzheimer´s disease
People prefer to receive a reward rather sooner than later, which means that people put a smaller value on a reward they have to wait for (= delay discounting, DD). But when people get to choose between
Mapping brain shrinkage in dementia
Sick arteries give their small cousins a beating: new insight into vascular pathology in Alzheimer’s disease
Vitamins and minerals in control of serious diseases?
Self-reference effect on memory and well-being in patients at risk for Alzheimer’s disease
Metabolic imaging is new a tool to investigate blood-brain barrier in Alzheimer disease
Serotonergic drugs in the treatment of symptoms in Alzheimer’s disease

Alzheimer’s disease is a neurodegenerative disease showing alterations in neurotransmitters, above all in brain regions responsibles for cognition and emotions. In this disease, an imbalance between neurotransmitters, acetylcholine, GABA, glutamate, noradrenaline and serotonin are included. In brain
Melatonin and serotonin in psychiatric and brain disorders
Melatonin is well known as a treatment for jet lag, being naturally released by the brain when we close our eyes to go to sleep. However, recent research shows that melatonin is released by many, if not
How antioxidants may have a pro-oxidant effect?
Novel presenilin 1 mutation in familial late-onset Alzheimer’s disease
Music therapy eases depression, soothes agitation in nursing home residents with dementia
Endocrine regulation of Alzheimer’s disease. The Achilles heel of dementia and other neurological conditions
Alzheimer’s disease (AD) is the most common disorder of the central nervous system and the most frequent cause of devastating dementia in the elderly. Typified by loss of memory and by cognitive decline, AD lowers the quality